Key facts
- This page summarizes Redmile Group, LLC's Form 4 filing for RayzeBio, Inc..
- 6 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 21 Sep 2023, 21:30.
Redmile Group, LLC - 19 Sep 2023 Form 4 Insider Report for RayzeBio, Inc.
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- N/A
- Reported as of
- 19 Sep 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 21 Sep 2023, 21:30:28 UTC
- Prior SEC filing
- 14 Sep 2023
- Next SEC filing
- 03 Oct 2023
- Source filing
- View source filing
- Reporting owner signature
- By: /s/ Jeremy Green, Managing Member of Redmile Group, LLC
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Redmile Group, LLC filed Form 4 for RayzeBio, Inc. on 21 Sep 2023.
Change
- Previous filing in this sequence was filed on 14 Sep 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
RYZB
transaction
Common Stock
Conversion of derivative security
- Transaction value
- Shares
- +864,509
- Change %
- Price
- Shares after
- 864,509
- Date
- 19 Sep 2023
- Ownership
- See Footnote
- Footnotes
- F1, F2
RYZB
transaction
Common Stock
Conversion of derivative security
- Transaction value
- Shares
- +494,687
- Change %
- +57%
- Price
- Shares after
- 1,359,196
- Date
- 19 Sep 2023
- Ownership
- See Footnote
- Footnotes
- F1, F2
RYZB
transaction
Common Stock
Conversion of derivative security
- Transaction value
- Shares
- +498,510
- Change %
- +37%
- Price
- Shares after
- 1,857,706
- Date
- 19 Sep 2023
- Ownership
- See Footnote
- Footnotes
- F1, F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
RYZB
transaction
Derivative
Series B Preferred Stock
Conversion of derivative security
- Transaction value
- $0
- Shares
- -864,509
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 19 Sep 2023
- Ownership
- See Footnote
- Underlying class
- Common Stock
- Underlying amount
- 864,509
- Exercise price
- Footnotes
- F1, F2
RYZB
transaction
Derivative
Series C Preferred Stock
Conversion of derivative security
- Transaction value
- $0
- Shares
- -432,254
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 19 Sep 2023
- Ownership
- See Footnote
- Underlying class
- Common Stock
- Underlying amount
- 494,687
- Exercise price
- Footnotes
- F1, F2
RYZB
transaction
Derivative
Series D Preferred Stock
Conversion of derivative security
- Transaction value
- $0
- Shares
- -498,510
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 19 Sep 2023
- Ownership
- See Footnote
- Underlying class
- Common Stock
- Underlying amount
- 498,510
- Exercise price
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
Redmile Group, LLC is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 2 footnotes
Footnote F1
The shares of Series B preferred stock, Series C preferred stock and Series D preferred stock converted into shares of the Issuer's common stock automatically upon the closing of the Issuer's initial public offering for no consideration. None of the series of preferred stock had an expiration date.
Footnote F2
These securities are directly owned by Redmile Biopharma Investments II, L.P. (the "Fund") and may be deemed beneficially owned by Redmile Group, LLC ("Redmile") as investment manager of the Fund. The reported securities may also be deemed beneficially owned by Jeremy Green as the principal of Redmile. Each of Redmile and Mr. Green (the "Managing Persons") disclaims beneficial ownership of the reported securities except to the extent of their pecuniary interest therein. This report shall not be deemed an admission that such Managing Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.